Experienced in AIDS Dementia Complex

Juan M. Tiraboschi

Barcelona, CT, ES 
Experienced in AIDS Dementia Complex
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Juan Tiraboschi practices in Barcelona, Spain. Mr. Tiraboschi is rated as an Experienced expert by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are HIV/AIDS, AIDS Dementia Complex, Encephalitis, and Osteoporosis.

His clinical research consists of co-authoring 62 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of AIDS Dementia Complex.

Gender
Male

Locations

Barcelona, CT 08907, Spain
Other Locations
L'hospitalet De Llobregat, CT, Spain
Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
Enrollment Status: Terminated
Publish Date: June 26, 2024
Intervention Type: Drug
Study Drugs: GSK3640254, ABC/3TC, FTC/TAF, Dolutegravir
Study Phase: Phase 2
A Phase IIb, Randomized, Double-blind, Parallel-group Study to Assess the Efficacy, Safety, Tolerability, and Resistance Profile of GSK3640254 in Combination With Dolutegravir Compared to Dolutegravir Plus Lamivudine in HIV-1 Infected, Treatment-naïve Adults
A Phase IIb, Randomized, Double-blind, Parallel-group Study to Assess the Efficacy, Safety, Tolerability, and Resistance Profile of GSK3640254 in Combination With Dolutegravir Compared to Dolutegravir Plus Lamivudine in HIV-1 Infected, Treatment-naïve Adults
Enrollment Status: Terminated
Publish Date: December 14, 2023
Intervention Type: Drug
Study Drugs: GSK3640254, Dolutegravir, Lamivudine
Study Phase: Phase 2
Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
Enrollment Status: Completed
Publish Date: July 06, 2022
Intervention Type: Drug
Study Drugs: Doravirine, Descovy
Study Phase: Phase 2
Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals
Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals
Enrollment Status: Completed
Publish Date: April 28, 2022
Intervention Type: Drug
Study Drugs: Doravirine, Descovy
Study Phase: Phase 3
View 3 Less Clinical Trials

62 Total Publications

Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size.
Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size.
Journal: International journal of molecular sciences
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tiraboschi's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile